Santen maintains the greatest share in Japan's prescription ophthalmic pharmaceutical market. This is a result of the Company's constant efforts in "Creation and Innovation" throughout the past over 120-year history. While working to maintain the top position in the Japanese prescription ophthalmic pharmaceutical market, in view of the further expansion of the global ophthalmic pharmaceutical market, Santen has also begun to commit itself to realizing a new vision: Developing Santen into a Specialized Pharmaceutical Company with a Global Presence.
Santen maintains the greatest share in Japan's prescription ophthalmic pharmaceutical market. This is a result of the Company's constant efforts in "Creation and Innovation" throughout the past over 120-year history. While working to maintain the top position in the Japanese prescription ophthalmic pharmaceutical market, in view of the further expansion of the global ophthalmic pharmaceutical market, Santen has also begun to commit itself to realizing a new vision: Developing Santen into a Specialized Pharmaceutical Company with a Global Presence.
Santen maintains the greatest share in Japan's prescription ophthalmic pharmaceutical market. This is a result of the Company's constant efforts in "Creation and Innovation" throughout the past over 120-year history. While working to maintain the top position in the Japanese prescription ophthalmic pharmaceutical market, in view of the further expansion of the global ophthalmic pharmaceutical market, Santen has also begun to commit itself to realizing a new vision: Developing Santen into a Specialized Pharmaceutical Company with a Global Presence.